The all-cash deal has involved Novo Holdings acquiring Catalent for $16.5bn, including debt. It will then sell three of ...

Novo Nordisk's CagriSema Phase 3 data showed 22.7% weight loss, missing the company's own 25% target, causing a 20% drop in ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage list after determining that Lilly’s ...

Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.

President-elect Donald Trump upon returning to Washington will seek to jettison what he sees as excessive federal spending, and Wells Fargo economists project there will be marginal reductions next ...

EST Novo Nordisk (NVO) says patients on Cagrisema lost 22.7% of weight in trial Pick the best stocks and maximize your portfolio:Discover ...

EST Novo Nordisk (NVO) to further explore weight loss potential of CagrisemaPick the best stocks and maximize your portfolio:Discover ...

Prothena stock catapulted Thursday after the company's Roche-partnered Parkinson's treatment showed promise in a midstage ...